An increased risk of adverse pregnancy and neonatal outcomes has been reported for pregnancies in women with several rheumatic and systemic autoimmune diseases including RA, PsA, and SLE, the Medical Independent reports.
New data presented at the 2022 EULAR Congress show that foetal morbidity and severe maternal morbidity occur at a higher rate in women with SLE compared to those without. An increased risk of adverse pregnancy outcomes was also reported for women with spondyloarthritis (SpA), and shown to be associated with steroid use in women with RA.
These findings are from a retrospective study in over 50,000 women with SLE and delivery-related hospital admissions, which were presented at the EULAR 2022 Congress. The group’s findings show patients with SLE had a higher risk of foetal morbidity than women without SLE.
- Medical Independent: New data on pregnancy outcomes in women with rheumatic disease